UnitedHealth Group Inc (UNH) Holdings Increased by Raymond James Trust N.A.

Raymond James Trust N.A. raised its holdings in UnitedHealth Group Inc (NYSE:UNH) by 1.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 54,949 shares of the healthcare conglomerate’s stock after acquiring an additional 956 shares during the period. UnitedHealth Group makes up 0.9% of Raymond James Trust N.A.’s investment portfolio, making the stock its 23rd largest position. Raymond James Trust N.A.’s holdings in UnitedHealth Group were worth $14,619,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Welch Group LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $106,000. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $107,000. Northwest Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $117,000. Fort L.P. purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $119,000. Finally, Kiley Juergens Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $178,000. 85.35% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities analysts recently weighed in on UNH shares. Citigroup cut UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price objective on the stock. in a report on Monday, September 10th. Raymond James raised their price target on UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Morgan Stanley raised their price target on UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 5th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 11th. One research analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $279.26.

In other news, CEO Steven H. Nelson sold 8,142 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the sale, the chief executive officer now directly owns 22,496 shares in the company, valued at approximately $5,961,440. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Richard T. Burke sold 20,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the sale, the director now owns 1,720,112 shares in the company, valued at $453,094,701.92. The disclosure for this sale can be found here. Over the last quarter, insiders sold 94,568 shares of company stock worth $24,950,027. Corporate insiders own 0.87% of the company’s stock.

Shares of UNH stock opened at $272.57 on Wednesday. The company has a market capitalization of $256.06 billion, a PE ratio of 27.07, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. UnitedHealth Group Inc has a fifty-two week low of $196.37 and a fifty-two week high of $272.81. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.75 and a current ratio of 0.75.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The business’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period last year, the company earned $2.66 EPS. Research analysts forecast that UnitedHealth Group Inc will post 12.72 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 18th. Stockholders of record on Friday, September 7th were given a $0.90 dividend. The ex-dividend date was Thursday, September 6th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.32%. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Hedge Funds – Risk or Reward?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply